Fenghuang Zhan

基本信息

Career Trajectory

Bio

My research interests include: 1) Understanding how the genetic alterations in cancer cells contribute to tumor progression, alter treatment response, and create vulnerabilities that may be targeted therapeutically and 2) Develop new therapeutic strategies to overcome chemo and immune therapy resistance.

Research Interests

Papers共 314 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Prognostic Gene Expression and Microrna Profiling Signatures and Genetic Alterations in Primary Testicular Diffuse Large B-cell Lymphoma

Ken Young, Wen-Yu Shi, Zijun Xu-Monette, Youchao Jia,Alexandar Tzankov,Heounjeong Go,Ling Li,Maurilio Ponzoni, Yafei Wang,Qiongli Zhai,Anamarija Perry,Shi Wang,Xiaoxiao Wang,April Chiu,Mina Xu,Carlo Visco,Karen Dybkaer,Henry Withers,Mark Long, Alyssa Yuan,Yi Miao,Jianyong Li,Everardo Macias, Wen Shuai,Bangchen Wang,Govind Bhagat,Youli Zu,Zenggang Pan, William Choi,Santiago Montes-Moreno,Weina Chen, J Han van Krieken,Michael Møller,Fenghuang Zhan, Ben Parsons,Shanxiang Zhang,Eric Hsi,Aliyah Sohani,Jeremy Abramson,Andrés Ferreri,Bing Xu,Yong Li

Research square (2025)

Cited0Views0WOSBibtex

Polyclonal Plasma Cell (polypc) Signature As a Key Indicator for Predicting the Progression of MGUS to Multiple Myeloma

Fumou Sun, Yan Cheng, Catherine Ma,Hongwei Xu, Clyde Bailey,David Mery, Timothy Cody Ashby,Daisy Alapat,Yong Li,Ken H Young,Samer Al Hadidi,Sharmilan Thanendrarajan,Carolina Schinke,Maurizio Zangari,Frits van Rhee,Guido Tricot, John D Shaughnessy,Fenghuang Zhan

Cancer biomarkers section A of Disease markersno. 6 (2025): 18758592251344936-18758592251344936

Cited0Views0WOSBibtex

Prior Exposure to Belantamab Mafodotin Influences Outcomes with Idecabtagene Vicleucel in Patients with Multiple Myeloma

Bhavesh Mohan Lal,Marah Alzubi,Jawad Alrawabdeh,John D Shaughnessy,Fenghuang Zhan,Eric R Siegel,Carolina Schinke,Sharmilan Thanendrarajan,Maurizio Zangari,Frits van Rhee,Samer Al Hadidi

Blood advancesno. 9 (2025): 2155-2158

Cited0Views0WOSBibtex

Long Term Follow Up of Total Therapy IV: A Phase III Clinical Trial for Standard Risk Multiple Myeloma

Samer Al Hadidi,Obada Ababneh,Carolina Schinke,Sharmilan Thanendrarajan,Clyde Bailey,Robert Smith,Susan Panozzo,Daisy Alapat,Guido Tricot,John Shaughnessy,Fenghuang Zhan,Jeffrey Sawyer,Eric R. Siegel,Bart Barlogie,Frits van Rhee,Maurizio Zangari

Blood Advances (2025)

Cited0Views0WOSBibtex

Long-Term Follow-Up of Patients with Multiple Myeloma Treated on Earlier Total Therapy Protocols: A Secondary Analysis of 3 Clinical Trials

Samer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke,Sharmilan Thanendrarajan,Eric R Siegel, Clyde Bailey,Robert Smith, Susan B Panozzo,Maurizio Zangari,Guido Tricot, John D Shaughnessy,Fenghuang Zhan,Jeffrey Sawyer,Bart Barlogie,Frits van Rhee

JAMA oncology (2025)

Cited0Views0WOSBibtex

Targeting Caseinolytic Mitochondrial Matrix Peptidase, a Novel Contributor to the Pathobiology of High-Risk Multiple Myeloma

Li Qin,Luz Yurany Moreno Rueda, Upasana Ray,Iqbal Mahmud,Lin Tan,Philip L Lorenzi, Suyu Liu,Heather Lin,David E Mery,Fenghuang Zhan,John D Shaughnessy,Qing Yi, Maria Jose Acevedo Calado,Hua Wang,Elisabet E Manasanch,Hans C Lee,Krina K Patel,Isere Kuiatse,David E Symer,Robert Z Orlowski

Bloodno. 22 (2025): 2614-2629

Cited0Views0WOSBibtex

Single-cell Analysis of Neoplastic Plasma Cells Identifies Myeloma Pathobiology Mediators and Potential Targets

Luz Yurany Moreno Rueda,Hua Wang,Keiko Akagi,Minghao Dang, Amishi Vora,Li Qin,Hans C. Lee,Krina K. Patel,Pei Lin,David E. Mery,Fenghuang Zhan,John D. Shaughnessy,Qing Yi, Yang Song,Bo Jiang,Maura L. Gillison,Sheeba K. Thomas,Donna M. Weber,Lixia Diao,Jing Wang

Cell Reports Medicinepp.101925, (2025)

Cited0Views0WOSBibtex

Of Seven Molecular Subtypes in MGUS the Low Bone Disease (LB) Subtype Exhibits Resistance to Multiple Myeloma Progression

Catherine Ma,Fumou Sun,Clyde Bailey, Hongwei Xu,Samer Al Hadidi,Carolina Schinke,Maurizio Zangari,Sharmilan Thanendrarajan,Frits van Rhee,John D Shaughnessy, Jr,Fenghuang Zhan

Bloodno. Supplement 1 (2024): 4676-4676

Cited0Views0Bibtex

Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience

Bhavesh Mohan Lal, Toshali Pandey,Marah Alzubi,Jawad Alrawabdeh,John D. Shaughnessy Jr,Fenghuang Zhan,Eric Siegel,Carolina Schinke,Sharmilan Thanendrarajan,Maurizio Zangari,Frits van Rhee,Samer Al Hadidi

BLOOD (2024): 2405-2406

Cited0Views0WOSNATUREBibtex

Bispecific BCMA/CD24 CAR-T Cells Control Multiple Myeloma Growth

Nature communicationsno. 1 (2024): 615-615

Cited7Views0WOSNATUREBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 314 篇Author StatisticsCo-AuthorSimilar Experts